tiprankstipranks
Bio-Techne (TECH)
NASDAQ:TECH
US Market
TECH
Bio-Techne
RESEARCH TOOLSreports
Want to see TECH full AI Analyst Report?

Bio-Techne (TECH) Ratios

534 Followers

Bio-Techne Ratios

TECH's free cash flow for Q4 2026 was $0.66. For the 2026 fiscal year, TECH's free cash flow was decreased by $ and operating cash flow was $0.21. See a summary of the company’s cash flow.
Ratios
TTM
Jun 26Jun 25Jun 24Jun 23
Liquidity Ratios
Current Ratio
 4.55 4.55 3.46 3.87 4.84
Quick Ratio
 3.35 3.35 2.38 2.75 3.50
Cash Ratio
 1.62 1.62 0.92 0.95 1.41
Solvency Ratio
 0.58 0.49 0.29 0.44 0.58
Operating Cash Flow Ratio
 1.78 1.78 1.64 1.88 1.98
Short-Term Operating Cash Flow Coverage
 0.00 19.56 0.00 0.00 0.00
Net Current Asset Value
$ 265.90M$ 173.63M$ -30.76M$ -17.60M$ -50.69M
Leverage Ratios
Debt-to-Assets Ratio
 0.11 0.11 0.17 0.16 0.17
Debt-to-Equity Ratio
 0.14 0.14 0.23 0.20 0.23
Debt-to-Capital Ratio
 0.12 0.12 0.19 0.17 0.19
Long-Term Debt-to-Capital Ratio
 0.09 0.09 0.15 0.13 0.15
Financial Leverage Ratio
 1.23 1.27 1.33 1.31 1.34
Debt Service Coverage Ratio
 52.66 13.99 22.54 18.78 36.01
Interest Coverage Ratio
 46.60 46.60 12.02 13.13 26.66
Debt to Market Cap
 0.02 0.02 0.04 0.03 0.03
Interest Debt Per Share
 1.89 1.89 2.87 2.76 2.97
Net Debt to EBITDA
 0.07 0.07 1.30 0.86 0.60
Profitability Margins
Gross Profit Margin
65.77%65.77%64.80%66.41%67.72%
EBIT Margin
20.25%20.25%8.77%17.38%30.78%
EBITDA Margin
28.27%28.27%17.78%27.02%40.21%
Operating Profit Margin
20.73%20.73%8.38%17.83%26.30%
Pretax Profit Margin
19.81%19.81%8.07%16.02%29.79%
Net Profit Margin
14.97%14.97%6.02%14.50%25.10%
Continuous Operations Profit Margin
14.97%14.97%6.02%14.50%25.11%
Net Income Per EBT
75.56%75.56%74.55%90.53%84.23%
EBT Per EBIT
95.55%95.55%96.29%89.84%113.29%
Return on Assets (ROA)
7.03%6.79%2.87%6.22%10.81%
Return on Equity (ROE)
8.90%8.63%3.83%8.13%14.51%
Return on Capital Employed (ROCE)
10.40%10.01%4.29%8.12%11.91%
Return on Invested Capital (ROIC)
7.81%7.52%3.18%7.32%9.99%
Return on Tangible Assets
13.90%12.99%6.06%13.73%23.17%
Earnings Yield
1.61%1.65%0.91%1.49%2.22%
Efficiency Ratios
Receivables Turnover
 5.61 5.51 5.90 4.80 5.20
Payables Turnover
 3.96 15.58 16.96 10.25 14.29
Inventory Turnover
 2.13 2.13 2.27 2.17 2.14
Fixed Asset Turnover
 4.06 4.06 3.82 3.38 3.50
Asset Turnover
 0.47 0.45 0.48 0.43 0.43
Working Capital Turnover Ratio
 2.18 2.40 2.74 2.44 2.46
Cash Conversion Cycle
 144.62 214.57 201.44 208.92 215.36
Days of Sales Outstanding
 65.06 66.24 61.91 76.02 70.15
Days of Inventory Outstanding
 171.76 171.76 161.05 168.50 170.76
Days of Payables Outstanding
 92.20 23.43 21.52 35.59 25.55
Operating Cycle
 236.82 238.00 222.96 244.51 240.91
Cash Flow Ratios
Operating Cash Flow Per Share
 1.87 1.87 1.83 1.90 1.62
Free Cash Flow Per Share
 1.69 1.69 1.63 1.50 1.38
CapEx Per Share
 0.18 0.18 0.20 0.40 0.24
Free Cash Flow to Operating Cash Flow
 0.90 0.90 0.89 0.79 0.85
Dividend Paid and CapEx Coverage Ratio
 3.71 3.71 3.53 2.64 2.87
Capital Expenditure Coverage Ratio
 10.12 10.12 9.27 4.76 6.65
Operating Cash Flow Coverage Ratio
 1.01 1.01 0.65 0.71 0.56
Operating Cash Flow to Sales Ratio
 0.24 0.24 0.24 0.26 0.22
Free Cash Flow Yield
2.32%2.39%3.17%2.09%1.68%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 61.94 60.38 109.47 67.18 44.98
Price-to-Sales (P/S) Ratio
 9.34 9.07 6.64 9.74 11.29
Price-to-Book (P/B) Ratio
 5.36 5.23 4.22 5.46 6.52
Price-to-Free Cash Flow (P/FCF) Ratio
 43.11 41.86 31.59 47.83 59.36
Price-to-Operating Cash Flow Ratio
 38.70 37.73 28.18 37.77 50.44
Price-to-Earnings Growth (PEG) Ratio
 0.40 0.41 -1.95 -1.64 9.73
Price-to-Fair Value
 5.36 5.23 4.22 5.46 6.52
Enterprise Value Multiple
 33.11 32.15 38.67 36.92 28.67
Enterprise Value
 11.37B 11.04B 8.39B 11.56B 13.10B
EV to EBITDA
 33.11 32.15 38.67 36.92 28.67
EV to Sales
 9.36 9.09 6.88 9.97 11.53
EV to Free Cash Flow
 43.20 41.95 32.69 48.97 60.63
EV to Operating Cash Flow
 38.93 37.81 29.16 38.67 51.51
Tangible Book Value Per Share
 5.32 5.32 3.63 3.74 3.56
Shareholders’ Equity Per Share
 13.52 13.52 12.18 13.12 12.51
Tax and Other Ratios
Effective Tax Rate
 0.24 0.24 0.25 0.09 0.16
Revenue Per Share
 7.79 7.79 7.74 7.35 7.23
Net Income Per Share
 1.17 1.17 0.47 1.07 1.81
Tax Burden
 0.76 0.76 0.75 0.91 0.84
Interest Burden
 0.98 0.98 0.92 0.92 0.97
Research & Development to Revenue
 0.08 0.08 0.08 0.08 0.08
SG&A to Revenue
 0.37 0.37 0.34 0.34 0.31
Stock-Based Compensation to Revenue
 0.03 0.03 0.03 0.03 0.03
Income Quality
 1.61 1.61 3.92 1.78 0.89
Currency in USD